BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1720
-0.0080 (-4.44%)
Mar 5, 2026, 1:40 PM EST

BioLargo Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.883.553.541.850.96
Cash & Short-Term Investments
3.883.553.541.850.96
Cash Growth
9.44%0.25%91.19%92.41%34.36%
Receivables
0.623.172.611.060.51
Inventory
0.310.330.150.120.24
Prepaid Expenses
0.310.090.060.120.09
Total Current Assets
5.117.146.363.151.8
Property, Plant & Equipment
3.013.191.751.150.51
Long-Term Investments
-0.010.020.030.05
Other Long-Term Assets
0.190.180.070.520.66
Total Assets
8.3110.518.214.863.02
Accounts Payable
2.81.071.350.90.5
Accrued Expenses
-0.150.30.280.29
Current Portion of Long-Term Debt
1.480.550.30.10.31
Current Portion of Leases
0.310.190.110.10.1
Current Unearned Revenue
0.28-0.30.020.09
Other Current Liabilities
0.190.680.360.180.08
Total Current Liabilities
5.062.652.711.581.37
Long-Term Debt
0.60.530.290.50.37
Long-Term Leases
1.121.2810.770.35
Total Liabilities
6.794.4642.852.09
Common Stock
0.210.20.20.190.17
Additional Paid-In Capital
165.32158.33154.02148.44143.72
Retained Earnings
-161.28-149.5-147.1-143.59-139.12
Comprehensive Income & Other
-0.21-0.18-0.28-0.15-0.12
Total Common Equity
4.048.856.844.884.65
Minority Interest
-2.52-2.8-2.64-2.87-3.72
Shareholders' Equity
1.536.064.22.010.93
Total Liabilities & Equity
8.3110.518.214.863.02
Total Debt
3.512.551.71.471.13
Net Cash (Debt)
0.370.991.840.38-0.17
Net Cash Growth
-62.78%-46.01%380.68%--
Net Cash Per Share
0.000.000.010.00-0.00
Filing Date Shares Outstanding
319.75301.3295.55283.19262.72
Total Common Shares Outstanding
317.38301.27292.95278.46255.89
Working Capital
0.054.493.651.580.43
Book Value Per Share
0.010.030.020.020.02
Tangible Book Value
4.048.856.844.884.65
Tangible Book Value Per Share
0.010.030.020.020.02
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.